A Journey Endometrial Cancer Clinical Trials - Revealing Engagement Patterns Among Individuals Affected by Endometrial Cancer

Power Life Sciences Inc.1 site in 1 country500 target enrollmentSeptember 2024

ConditionsEndometrial Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Endometrial Cancer
Sponsor: Power Life Sciences Inc.
Enrollment: 500
Locations: 1
Primary Endpoint: Number of patients who decide to enroll in an endometrial cancer clinical research
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The study intends to investigate the personal experiences of endometrial cancer patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal.

The data collected from this study will help improve future outcomes for all endometrial cancer patients as well as those in under-represented demographic groups.

Registry

clinicaltrials.gov

Start Date

September 2024

End Date

September 2026

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Power Life Sciences Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients diagnosed with endometrial cancer
•Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
•Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.

Exclusion Criteria

•Refusal of consent
•Women of childbearing potential without a negative pregnancy test; or women who are lactating.
•Any serious and/or unstable pre-existing medical disorders